Rodney G Bowden, Ronald L Wilson, Mindy Gentile, Songthip Ounpraseuth, Page Moore, Brian C Leutholtz
Journal: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2007;17(2):126-31
PMID: 17321952
OBJECTIVE
The purpose of this study was to investigate the effects of orally administered over-the-counter omega-3 (n-3) fatty acid supplements on primary patency of polytetrafluoroethylene (PTFE) grafts.
DESIGN
This study was conducted with a triple-blind, permuted-block, randomized, placebo-controlled experimental design.
SETTING
Dialysis clinics with patients who, in accordance with physician diagnosis, needed a new PTFE graft.
PATIENTS AND OTHER PARTICIPANTS
Patients on long-term hemodialysis with newly placed PTFE grafts who were unable to receive a native arteriovenous fistula.
INTERVENTION
Patients were followed prospectively for 8 months after they had been placed into an n-3 fatty acid or control group and were monitored for primary patency.
MAIN OUTCOME VARIABLE
Primary patency of the PTFE graft.
RESULTS
The n-3 fatty acid group had a mean PTFE graft primary patency rate of 254.2 days (SEM = 51.8), and the control group had a mean PTFE graft primary patency rate of 254.1 days (SEM = 34.6), revealing no significant difference in survival time between groups.
CONCLUSIONS
No significant differences in primary patency rates were noted in the experimental and control groups.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.